Human coronavirus OC43 nanobody neutralizes virus and protects mice from infection

- Adair, Amy, Tan, Li Lynn, Pymm, Phillip, Tham, Wai-Hong, Feng, Jackson, Girkin, Jason, Bryant, Nathan, Wang, Mingyang, Mordant, Francesca, Chan, Li-Jin, Bartlett, Nathan W., Subbarao, Kanta

An update in club cell biology and its potential relevance to chronic obstructive pulmonary disease

- Blackburn, Jessica B., Li, Ngan Fung, Bartlett, Nathan W., Richmond, Bradley W.

Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level

- Akerman, Anouschka, Milogiannakis, Vanessa, Caguicla, Joanna, Li, Daiyang, Walker, Gregory, Amatayakul-Chantler, Supavadee, Roth, Nathan, Manni, Sandro, Hauser, Thomas, Barnes, Thomas, Condylios, Anna, Yeang, Malinna, Jean, Tyra, Wong, M, Foster, CSP, Sato, K, Lee, S, Song, Y, Mao, L, Sigmund, A, Phu, A, Vande More, AM, Hunt, S, Esneau, Camille, Douglas, M, Caterson, I, Britton, W, Sandgren, K, Bull, R, Lloyd, A, Triccas, J, Tangye, S, Bartlett, Nathan W., Darley, D, Silva, Mariana Ruiz, Matthews, G, Stark, DJ, Petoumenos, K, Rawlinson, WD, Murrell, B, Brilot, F, Cunningham, AL, Kelleher, AD, Aggarwal, A, Turville, SG, Ison, Timothy, Fichter, Christina, Lopez, Joseph A., Chandra, Deborah, Naing, Zin

Mechanical forces suppress antiviral innate immune responses from asthmatic airway epithelial cells following rhinovirus infection

- Veerati, Punnam Chander, Reid, Andrew T., Nichol, Kristy S., Wark, Peter A. B., Knight, Darryl A., Bartlett, Nathan W., Grainge, Christopher L.

Rhinovirus infection induces secretion of endothelin-1 from airway epithelial cells in both in vitro and in vivo models

- Dy, Alane Blythe C., Girkin, Jason, Bochkov, Yury A., Bartlett, Nathan W., Park, Jin-Ah, Marrocco, Antonella, Collison, Adam, Mwase, Chimwemwe, O'Sullivan, Michael J., Phung, Thien-Khoi N., Mattes, Joerg, Koziol-White, Cynthia, Gern, James E.

Severe asthma ILC2s demonstrate enhanced proliferation that is modified by biologics

- Malik, Bilal, Bartlett, Nathan W., Upham, John W., Nichol, Kristy S., Harrington, John, Wark, Peter A. B.

Upper Respiratory Tract OC43 Infection Model for Investigating Airway Immune-modifying Therapies

- Girkin, Jason L. N., Bryant, Nathan E., Loo, Su-Ling, Hsu, Alan, Kanwal, Amama, Williams, Teresa C., Maltby, Steven, Turville, Stuart G., Wark, Peter A. B., Bartlett, Nathan W.

A Persistent Neutrophil-Associated Iimmune Signature Characterizes Post-COVID-19 Pulmonary Sequelae

- George, Peter M., Reed, Anna, Man, William D-C., Kaul, Sundeep, Singh, Suveer, Lamb, Georgia, Faizi, Fatima K., Schuliga, Michael, Read, Jane, Burgoyne, Thomas, Pinto, Andreia L., Micallef, Jake, Desai, Sujal R., Bauwens, Emilie, Candiracci, J, Bougoussa, M, Herzog, M, Raman, L, Ahmetaj-Shala, B, Turville, S, Aggarwal, A, Farne, HA, Dalla Pria, A, Devaraj, Anand, Aswani, AD, Patella, F, Borek, WE, Mitchell, JA, Bartlett, Nathan W., Dokal, A, Xu, X-N, Kelleher, P, Shah, A, Singanayagam, A, Faiez, Tasnim Shahridan, Laverty, Sarah, Kanwal, Amama, Esneau, Camille, Liu, Michael K. C., Kamal, Faisal

Airway mucins promote immunopathology in virus-exacerbated chronic obstructive pulmonary disease

- Singanayagam, Aran, Footitt, Joseph, Marczynski, Matthias, Radicioni, Giorgia, Cross, Michael T., Finney, Lydia J., Trujillo-Torralbo, Maria-Belen, Calderazzo, Maria, Zhu, Jie, Aniscenko, Julia, Clarke, Thomas B., Molyneaux, Philip L., Bartlett, Nathan W., Moffatt, Miriam F., Cookson, William O., Wedzicha, Jadwiga, Evans, Christopher M., Boucher, Richard C., Kesimer, Mehmet, Lieleg, Oliver, Mallia, Patrick, Johnston, Sebastian L.

Conditionally reprogrammed asthmatic bronchial epithelial cells express lower FOXJ1 at terminal differentiation and lower IFNs following RV-A1 infection

- Veerati, Punnam Chander, Nichol, Kristy S., Read, Jane M., Bartlett, Nathan W., Wark, Peter A. B., Knight, Darryl A., Grainge, Christopher L., Reid, Andrew T.

IL-25 blockade augments antiviral immunity during respiratory virus infection

- Williams, Teresa C., Loo, Su-Ling, Jackson, Crystal L., Alton, Kirby, Shimkets, Richard A., Girkin, Jason L., Bartlett, Nathan W., Nichol, Kristy S., Reid, Andrew T., Veerati, Punnam C., Esneau, Camille, Wark, Peter A. B., Grainge, Christopher L., Knight, Darryl A., Vincent, Thomas

Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell

- Girkin, Jason L. N., Maltby, Steven, Bartlett, Nathan W.

Understanding rhinovirus circulation and impact on illness

- Esneau, Camille, Duff, Alexandra Cate, Bartlett, Nathan W.

A cGAS-dependent response links DNA damage and senescence in alveolar epithelial cells: a potential drug target in IPF

- Schuliga, Michael, Kanwal, Amama, Read, Jane, Blokland, Kaj E. C., Burgess, Janette K., Prele, Cecilia M., Mutsaers, Steven E., Grainge, Christopher, Thomson, Claire, James, Allen, Bartlett, Nathan W., Knight, Darryl A.

Blood interferon-a levels and severity, outcomes, and inflammatory profiles in hospitalized COVID-19 patients

- Contoli, Marco, Papi, Alberto, Tomassetti, Luca, Rizzo, Paola, Vieceli Dalla Sega, Francesco, Fortini, Francesca, Torsani, Francesca, Morandi, Luca, Ronzoni, Luca, Zucchetti, Ottavio, Pavasini, Rita, Fogagnolo, Alberto, Volta, Carlo Alberto, Bartlett, Nathan W., Johnston, Sebastian L., Spadaro, Savino, Campo, Gianluca

Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon

- Finney, Lydia J., Glanville, Nicholas, Farne, Hugo, Aniscenko, Julia, Fenwick, Peter, Kemp, Samuel V., Trujillo-Torralbo, Maria-Belen, Loo, Su Ling, Calderazzo, Maria Adelaide, Wedzicha, Jadwiga A., Mallia, Patrick, Bartlett, Nathan W., Johnston, Sebastian L., Singanayagam, Aran

miR-122 promotes virus-induced lung disease by targeting SOCS1

- Collison, Adam M., Sokulsky, Leon A., Johnston, Sebastian L., Foster, Paul S., Mattes, Joerg, Kepreotes, Elizabeth, de Siqueira, Ana Pereira, Morten, Matthew, Edwards, Michael R., Walton, Ross P., Bartlett, Nathan W., Yang, Ming, Nguyen, Thi Hiep

Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model

- Proud, Pamela C., Tsitoura, Daphne, Watson, Robert J., Chua, Brendon Y., Aram, Marilyn J., Bewley, Kevin R., Cavell, Breeze E., Cobb, Rebecca, Dowall, Stuart, Fotheringham, Susan A., Ho, Catherine M. K., Lucas, Vanessa, Ngabo, Didier, Rayner, Emma, Ryan, Kathryn A., Slack, Gillian S., Thomas, Stephen, Wand, Nadina I., Yeates, Paul, Demaison, Christophe, Zeng, Weiguang, Holmes, Ian, Jackson, David C., Bartlett, Nathan W., Mercuri, Francesca, Carroll, Miles W.

Rhinovirus-induced CCL17 and CCL22 in asthma exacerbations and differential regulation by STAT6

- Williams, Teresa C., Jackson, David J., Maltby, Steven, Walton, Ross P., Ching, Yee-Mann, Glanville, Nicholas, Singanayagam, Ara, Brewins, Jennifer J., Clarke, Deborah, Hirsman, Aurica G., Loo, Su-Ling, Wei, Lan, Beale, Janine E., Casolari, Paolo, Caramori, Gaetano, Papi, Alberto, Belvisi, Maria, Wark, Peter A. B., Johnston, Sebastian L., Edwards, Michael R., Bartlett, Nathan W.

TLR2-mediated activation of innate responses in the upper airways confers antiviral protection of the lungs

- Deliyannis, Georgia, Wong, Chinn Yi, McQuilten, Hayley A., Bachem, Annabell, Clarke, Michele, Jia, Xiaoxiao, Horrocks, Kylie, Zeng, Weiguang, Girkin, Jason, Scott, Nichollas E., Londrigan, Sarah L., Reading, Patrick C., Bartlett, Nathan W., Kedzierska, Katherine, Brown, Lorena E., Mercuri, Francesca, Demaison, Christophe, Jackson, David C., Chua, Brendon Y.